Register entry

Sanofi Winthrop Industrie

Registered sites
0
Drug products
30
Live patents
0
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Catalogue

Marketed products

30

Showing 30 of 30.

BrandGeneric nameFormCategory
-APOMORPHINE HYDROCHLORIDEPOWDERBULK INGREDIENT
-APOMORPHINE HYDROCHLORIDEPOWDERBULK INGREDIENT
-CHLORPROMAZINE HYDROCHLORIDEPOWDERBULK INGREDIENT
-Diltiazem HydrochlorideCAPSULE, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Diltiazem HydrochlorideCAPSULE, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Diltiazem HydrochlorideCAPSULE, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Diltiazem HydrochlorideCAPSULE, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Diltiazem HydrochlorideCAPSULE, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-DronedaroneTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-FEXOFENADINE HYDROCHLORIDETABLET, FILM COATED, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-FEXOFENADINE HYDROCHLORIDETABLET, FILM COATED, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-Fexofenadine Hydrochloride and Pseudoephedrine HydrochlorideTABLET, EXTENDED RELEASEDRUG FOR FURTHER PROCESSING
-HydroxocobalaminPOWDERBULK INGREDIENT
-Hydroxocobalamin AcetatePOWDERBULK INGREDIENT
-IrbesartanTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-IrbesartanTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-IrbesartanTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-NALOXONE HYDROCHLORIDEPOWDERBULK INGREDIENT
-NALOXONE HYDROCHLORIDEPOWDERBULK INGREDIENT
-NALOXONE HYDROCHLORIDEPOWDERBULK INGREDIENT
-Nalbuphine HydrochloridePOWDERBULK INGREDIENT
-Naltrexone HydrochloridePOWDERBULK INGREDIENT
-PROMETHAZINE HYDROCHLORIDEPOWDERBULK INGREDIENT
-TRIMIPRAMINE MALEATEPOWDERBULK INGREDIENT
-avanafilTABLETDRUG FOR FURTHER PROCESSING
-avanafilTABLETDRUG FOR FURTHER PROCESSING
-avanafilTABLETDRUG FOR FURTHER PROCESSING
-clopidogrel bisulfateTABLET, FILM COATEDDRUG FOR FURTHER PROCESSING
-sarilumabINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
-sarilumabINJECTION, SOLUTIONDRUG FOR FURTHER PROCESSING
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.